相關主題
商品描述
At the end of 2020, in the midst of the COVID-19 crisis, the progress of biotechnologies and artificial intelligence allowed the development of vaccines in less than a year, thus saving millions of human lives and preserving the global economy. The emergence of intelligent drugs is highlighted, with the promise of ultra-targeted, more effective, and safer treatments against a wide range of diseases. Personalized medicine then becomes realistic, with computer-designed drugs, perfectly adapted to each individual, tested on virtual patients before their real use. In the near future, thanks to AI, new drugs will improve physical performance, stimulate cognitive abilities, prevent diseases, and slow down aging. A fascinating essay to understand the issues and challenges of this medical revolution from which we should all benefit!
商品描述(中文翻譯)
在2020年底，面對COVID-19危機，生物技術和人工智慧的進步使得疫苗在不到一年的時間內得以開發，從而拯救了數百萬人的生命並保護了全球經濟。智能藥物的出現備受矚目，承諾提供超精準、更有效且更安全的治療方案，針對各種疾病。個人化醫療因此變得現實，計算機設計的藥物能夠完美適應每個個體，並在實際使用前在虛擬病人身上進行測試。在不久的將來，得益於人工智慧，新藥物將改善身體表現、刺激認知能力、預防疾病並延緩衰老。
這是一篇引人入勝的文章，幫助我們理解這場醫療革命的議題和挑戰，讓我們都能受益！
作者簡介
Philippe Moingeon is an immunologist, former researcher, and Assistant Professor at Harvard Medical School (Boston, USA), Professor in AI and Health at Paris-Saclay University. He is a member of the French Academy of Pharmacy and an expert with the European Federation of Academies of Medicine on the deployment of AI in health.
作者簡介(中文翻譯)
菲利普·莫安戈（Philippe Moingeon）是一位免疫學家，曾任研究員，現為哈佛醫學院（美國波士頓）助理教授，並在巴黎-薩克萊大學擔任人工智慧與健康教授。他是法國藥學院的成員，並且是歐洲醫學學院聯盟在健康領域人工智慧應用方面的專家。
